These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15204165)

  • 21. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
    Kagy MK; Amonette R
    Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
    Moehrle M; Breuninger H; Schippert W; Häfner HM
    Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of imiquimod in skin cancer treatment.
    Urosevic M; Dummer R
    Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma.
    Gowda S; Tillman DK; Fitzpatrick JE; Gaspari AA; Goldenberg G
    J Cutan Pathol; 2009 Aug; 36(8):878-81. PubMed ID: 19586497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod.
    Stockfleth E; Ulrich C; Hauschild A; Lischner S; Meyer T; Christophers E
    Eur J Dermatol; 2002; 12(6):569-72. PubMed ID: 12459530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New cream to treat skin cancer? [news].
    Mayo Clin Health Lett; 2001 Mar; 19(3):4. PubMed ID: 11242841
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
    Vun Y; Siller G
    Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential treatment of giant basal cell carcinomas.
    Madan V; West CA; Murphy JV; Lear JT
    J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
    De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
    Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.
    Diluvio L; Campione E; Paternò EJ; Orlandi A; Terrinoni A; Chimenti S
    J Dermatolog Treat; 2009; 20(2):124-9. PubMed ID: 18991155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
    Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
    Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
    Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
    Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imiquimod and pulmonary embolism: a case report.
    Leroy B; Richez A; Wolf F; Descotes J; Vial T
    Therapie; 2014; 69(2):180-1. PubMed ID: 24926639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
    Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
    Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
    J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
    Quirk C; Gebauer K; Owens M; Stampone P
    Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
    Oster-Schmidt C; Altmeyer P; Stücker M
    Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
    [No Abstract]   [Full Text] [Related]  

  • 40. Photodynamic therapy for basal cell carcinoma.
    Fargnoli MC; Peris K
    Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.